Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Amneal Imatinib vs Gleevec in CML/GIST
NCT02103322Phase 3Completed
- Sponsor
- Amneal Pharmaceuticals, Inc.
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of imatinib in chronic myeloid leukemia (CML), gastrointestinal stromal tumor (GIST), sponsored by Amneal Pharmaceuticals, Inc.. Started Feb 2014; status: completed.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT02103322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103322.